Clinical Trial for Effectiveness and Safety Evaluation of Hemodiafilter
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 160 participants.
Also called NCT06454981
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 160 participants
- Sponsor
- Hangzhou Kaiyuan Suixi Medical Technology Co., Ltd
- Registry
-
NCT06454981
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT06454981. Randomized; no masking; primary purpose treatment. Start 2021-07-23 (actual); primary completion 2021-11-02 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Clinical Trial for Effectiveness and Safety Evaluation of Hemodiafilter
- Condition
- Renal Failure Chronic
- Intervention (Device)
- Hemodiafilter
- Intervention (Device)
- Fresenius Medical Care AG & Co.KGaA
- Lead sponsor
- Hangzhou Kaiyuan Suixi Medical Technology Co., Ltd
Record details
- Record id
cardio:ct-nct06454981- Content hash
8799749d704e272970abe7ec609f7bf29693a8d3df0bf58d6b81fe1a39cf021d